News Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
19.9 ^TWD	-0.75%		-0.50%	-21.34%

15/04	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI
21/03	Applied BioCode Announces CEO Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04	BU
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04	CI
Applied BioCode Announces Retirement of CEO Chris Bernard	22/03	BU
Applied BioCode Announces CEO Changes	22/03	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	28/23/28	BU
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	28/23/28	CI
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23/23/23	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	14/23/14	CI
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	12/23/12	BU
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12/23/12	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Applied BioCode Announces Distribution Agreement with Medline Industries	08/23/08	BU
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08/23/08	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	13/23/13	CI
Applied BioCode Announces 2022 Q4 and Full year Revenue	27/23/27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Applied BioCode Corporation

Equities

6598

KYG0488D1051

Summary

Filters